Home/Filings/4/0000950170-24-106476
4//SEC Filing

Ryder Steven 4

Accession 0000950170-24-106476

CIK 0001776111other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 5:17 PM ET

Size

5.2 KB

Accession

0000950170-24-106476

Insider Transaction Report

Form 4
Period: 2024-09-12
Ryder Steven
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-09-12+15,96315,963 total
    Exercise: $16.00Exp: 2034-09-11Common Stock (15,963 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

MBX Biosciences, Inc.

CIK 0001776111

Entity typeother

Related Parties

1
  • filerCIK 0001872868

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:17 PM ET
Size
5.2 KB